Skip to content

Physical Activity in Children With Type 1 Diabetes Study

The Feasibility of a Physical Activity Intervention for Children With Type 1 Diabetes Mellitus: Steps To Active Kids (STAK)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02144337
Enrollment
13
Registered
2014-05-22
Start date
2014-05-31
Completion date
2015-05-31
Last updated
2015-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Activity, Type 1 Diabetes Mellitus

Keywords

Physical activity, Type 1 Diabetes Mellitus, Children, Intervention

Brief summary

This study aims to test the feasibility of a physical activity intervention called the Steps To Active Kids (STAK) programme in children aged 9 - 11 years with Type 1 Diabetes Mellitus (T1DM).

Detailed description

The STAK programme promotes physical activity in children who have a chronic condition, low levels of physical activity, are overweight or who lack confidence to take part in physical activity. The intervention involves an Activity Diary, circuit training, pedometer step counting, daily physical activity monitoring and goal setting to promote long-term increases in physical activity and its associated health benefits. This randomised single-centre feasibility study will test whether the STAK programme is feasible for children with T1DM, in terms of acceptability, attractiveness and compliance and a qualitative process evaluation will aid the assessment of feasibility.

Interventions

BEHAVIORALSteps To Active Kids (STAK) programme

Intervention described in Arm/Group Description.

Sponsors

University of Nottingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Years to 11 Years
Healthy volunteers
No

Inclusion criteria

* Be aged between 9 and 11 years * Have a clinical diagnosis of Type 1 Diabetes Mellitus for at least 3 months * Be willing and able to comply with the study protocol * Be physically able to participate in physical activity * Have a parent/carer who provides informed consent

Exclusion criteria

* Be under the age of 9 years and over the age of 11 years * Have been diagnosed with Type 1 Diabetes Mellitus for less than 3 months * Have an injury or physical health condition that precludes their participation in physical activity * Have a psychiatric disorder that interferes with provision of assent, completion of measurements, intervention, or follow-up * Insufficient proficiency in English to comply with treatment or provide data

Design outcomes

Primary

MeasureTime frameDescription
Feasibility: Response RateResponse rate at T2Number of participants completing outcome measures at T2
Feasibility: Rate of Adherence to the InterventionParticipants were monitored for the duration of the STAK programme (6 weeks)Attendance at physical activity sessions and completion of activity diary Intervention group only as the Control group were not exposed to any intervention.
Feasibility: Number of Participants With Adverse EventsParticipants were followed from baseline to research completionNumber of participants experiencing and/or reporting adverse events.

Secondary

MeasureTime frameDescription
Change in Children's Self-efficacy Using CSAPPA Scale (Children's Self-Perceptions of Adequacy in and Predilection for Physical Activity)0 months (baseline) and 6 months (follow-up)
Change in Parental Hypoglycaemia Fear Using the Hypoglycaemia Fear Survey (HFS-Parent)0 months (baseline) and 6 months (follow-up)
Change in Children's Level of Physical Activity (Measured Subjectively Via Self-report Questionnaire)0 months (baseline) and 6 months (follow-up)
Change in Clinical Outcome Measures (Hba1c, Height, Weight)0 months (baseline) and 6 months (follow-up)Data collected as routine clinic procedure and will be used to assess changes in HbA1c and BMI from baseline to follow-up.

Countries

United Kingdom

Participant flow

Recruitment details

Recruitment through clinic (single-centre). Postal invitation to all children meeting eligibility criteria.

Pre-assignment details

Expression of interest request. Consent (parental) and assent (child) received from those who expressed an interest and agreed to participate.

Participants by arm

ArmCount
Steps To Active Kids (STAK) Programme
6 week Steps To Active Kids (STAK) physical activity programme (combined supervised and home-based physical activity). Steps To Active Kids (STAK) Programme: 6 week programme of combined supervised and home-based (non-supervised) physical activity.
8
Normal Daily Activity
Treatment as usual: children asked to continue normal daily activity as usual.
5
Total13

Withdrawals & dropouts

PeriodReasonFG000FG001
T2 Follow-up (Post-intervention)Lack of Efficacy11
T2 Follow-up (Post-intervention)Lost to Follow-up20
T2 Follow-up (Post-intervention)Withdrawal by Subject10
T3 Follow-up (3 Month Post-intervention)Lost to Follow-up20
T3 Follow-up (3 Month Post-intervention)Withdrawal by Subject10

Baseline characteristics

CharacteristicSteps To Active Kids (STAK) ProgrammeNormal Daily ActivityTotal
Age, Continuous10.1 years
STANDARD_DEVIATION 0.8
10.0 years
STANDARD_DEVIATION 1
10.1 years
STANDARD_DEVIATION 0.9
BMI19.5 kg/m^2
STANDARD_DEVIATION 3.8
20.5 kg/m^2
STANDARD_DEVIATION 3.4
19.9 kg/m^2
STANDARD_DEVIATION 3.5
CSAPPA Adequacy22.4 units on a scale
STANDARD_DEVIATION 1.8
20.0 units on a scale
STANDARD_DEVIATION 4.5
21.5 units on a scale
STANDARD_DEVIATION 3.1
CSAPPA Enjoyment10.6 units on a scale
STANDARD_DEVIATION 1.7
10.3 units on a scale
STANDARD_DEVIATION 1.5
10.5 units on a scale
STANDARD_DEVIATION 1.6
CSAPPA Predilection28.7 units on a scale
STANDARD_DEVIATION 4
29.0 units on a scale
STANDARD_DEVIATION 5
28.8 units on a scale
STANDARD_DEVIATION 4.1
CSAPPA total61.7 units on a scale
STANDARD_DEVIATION 5.7
59.3 units on a scale
STANDARD_DEVIATION 9.9
60.8 units on a scale
STANDARD_DEVIATION 7.1
HbA1c (mmol/mol)57.1 mmol/mol
STANDARD_DEVIATION 10.2
55.4 mmol/mol
STANDARD_DEVIATION 11.8
56.5 mmol/mol
STANDARD_DEVIATION 10.4
PHFS Behaviour21.9 units on a scale
STANDARD_DEVIATION 7.5
20.2 units on a scale
STANDARD_DEVIATION 2.6
21.8 units on a scale
STANDARD_DEVIATION 4.4
PHFS total42.8 units on a scale
STANDARD_DEVIATION 17.6
37.4 units on a scale
STANDARD_DEVIATION 11.5
42.7 units on a scale
STANDARD_DEVIATION 13.3
PHFS Worry21.2 units on a scale
STANDARD_DEVIATION 14.1
17.2 units on a scale
STANDARD_DEVIATION 9.8
20.8 units on a scale
STANDARD_DEVIATION 12.2
Race/Ethnicity, Customized
Black African
1 participants0 participants1 participants
Race/Ethnicity, Customized
Mixed race
1 participants0 participants1 participants
Race/Ethnicity, Customized
White British
6 participants5 participants11 participants
Self-reported physical activity56.8 units on a scale
STANDARD_DEVIATION 9.1
49.8 units on a scale
STANDARD_DEVIATION 5.7
54.16 units on a scale
STANDARD_DEVIATION 8.5
Sex: Female, Male
Female
6 Participants0 Participants6 Participants
Sex: Female, Male
Male
2 Participants5 Participants7 Participants
Years diagnosed5.1 years
STANDARD_DEVIATION 3.1
2.9 years
STANDARD_DEVIATION 2.3
4.3 years
STANDARD_DEVIATION 2.9

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 80 / 5
serious
Total, serious adverse events
0 / 80 / 5

Outcome results

Primary

Feasibility: Number of Participants With Adverse Events

Number of participants experiencing and/or reporting adverse events.

Time frame: Participants were followed from baseline to research completion

ArmMeasureValue (NUMBER)
Intervention GroupFeasibility: Number of Participants With Adverse Events0 number of participants
Primary

Feasibility: Rate of Adherence to the Intervention

Attendance at physical activity sessions and completion of activity diary Intervention group only as the Control group were not exposed to any intervention.

Time frame: Participants were monitored for the duration of the STAK programme (6 weeks)

ArmMeasureValue (NUMBER)
Intervention GroupFeasibility: Rate of Adherence to the Intervention75 percentage of the intervention group
Primary

Feasibility: Response Rate

Number of participants completing outcome measures at T2

Time frame: Response rate at T2

ArmMeasureValue (NUMBER)
Intervention GroupFeasibility: Response Rate4 number of participants
Control GroupFeasibility: Response Rate4 number of participants
Primary

Feasibility: Response Rate

Number of participants completing outcome measures at T3

Time frame: Response rate at T3

ArmMeasureValue (NUMBER)
Intervention GroupFeasibility: Response Rate5 Number of participants
Control GroupFeasibility: Response Rate5 Number of participants
Secondary

Change in Children's Level of Physical Activity (Measured Subjectively Via Self-report Questionnaire)

Time frame: 0 months (baseline) and 6 months (follow-up)

Secondary

Change in Children's Self-efficacy Using CSAPPA Scale (Children's Self-Perceptions of Adequacy in and Predilection for Physical Activity)

Time frame: 0 months (baseline) and 6 months (follow-up)

Secondary

Change in Clinical Outcome Measures (Hba1c, Height, Weight)

Data collected as routine clinic procedure and will be used to assess changes in HbA1c and BMI from baseline to follow-up.

Time frame: 0 months (baseline) and 6 months (follow-up)

Secondary

Change in Parental Hypoglycaemia Fear Using the Hypoglycaemia Fear Survey (HFS-Parent)

Time frame: 0 months (baseline) and 6 months (follow-up)

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026